David Richard Light
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$5.0MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $5.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 21, 2025 | NIH | SBIR Phase II Rapid Development of a Lead Aromatic Aldehyde Derivative with both Oxygen Dependent and Novel, Oxygen Independent Anti-Sickling Effects: Building on a Paradigm Shift in Sickle Cell Disease Therapy | $529K | IllExcor Therapeutics LLC |
| Jul 16, 2025 | NIH | SBIR Phase II Novel therapeutic approach for severe ARDS with a potent pharmacologic allosteric hemoglobin modifier | $798K | IllExcor Therapeutics LLC |
| Aug 7, 2024 | NIH | SBIR Phase II Rapid Development of a Lead Aromatic Aldehyde Derivative with both Oxygen Dependent and Novel, Oxygen Independent Anti-Sickling Effects: Building on a Paradigm Shift in Sickle Cell Disease Therapy | $888K | IllExcor Therapeutics LLC |
| Jul 27, 2024 | NIH | SBIR Phase II Novel therapeutic approach for severe ARDS with a potent pharmacologic allosteric hemoglobin modifier | $808K | IllExcor Therapeutics LLC |
| Aug 23, 2023 | NIH | SBIR Phase II Rapid Development of a Lead Aromatic Aldehyde Derivative with both Oxygen Dependent and Novel, Oxygen Independent Anti-Sickling Effects: Building on a Paradigm Shift in Sickle Cell Disease Therapy | $977K | IllExcor Therapeutics LLC |
| Jun 26, 2023 | NIH | SBIR Phase II Novel therapeutic approach for severe ARDS with a potent pharmacologic allosteric hemoglobin modifier | $746K | IllExcor Therapeutics LLC |
| Dec 28, 2020 | NIH | SBIR Phase I Novel therapeutic approach for severe ARDS with a potent pharmacologic allosteric hemoglobin modifier | $298K | IllExcor Therapeutics LLC |
Peer ranks
Federal funding#269
Awards as PI#250
Patents#273
Companies
- IllExcor Therapeutics LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.